nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—Naltrexone—alcohol dependence	0.339	1	CrCtD
Buprenorphine—OPRK1—alcohol dependence	0.0892	0.446	CbGaD
Buprenorphine—OPRD1—alcohol dependence	0.0629	0.314	CbGaD
Buprenorphine—OPRM1—alcohol dependence	0.0481	0.24	CbGaD
Buprenorphine—Butorphanol—Naltrexone—alcohol dependence	0.0468	0.222	CrCrCtD
Buprenorphine—Methylnaltrexone—Naltrexone—alcohol dependence	0.0468	0.222	CrCrCtD
Buprenorphine—OPRD1—Naltrexone—alcohol dependence	0.0429	0.267	CbGbCtD
Buprenorphine—Oxymorphone—Naltrexone—alcohol dependence	0.0392	0.185	CrCrCtD
Buprenorphine—Nalbuphine—Naltrexone—alcohol dependence	0.0392	0.185	CrCrCtD
Buprenorphine—Naloxone—Naltrexone—alcohol dependence	0.0392	0.185	CrCrCtD
Buprenorphine—OPRK1—Naltrexone—alcohol dependence	0.0359	0.224	CbGbCtD
Buprenorphine—OPRM1—Naltrexone—alcohol dependence	0.0316	0.197	CbGbCtD
Buprenorphine—CYP3A5—Disulfiram—alcohol dependence	0.00994	0.0619	CbGbCtD
Buprenorphine—ABCB1—Naltrexone—alcohol dependence	0.00696	0.0433	CbGbCtD
Buprenorphine—CYP2C9—Disulfiram—alcohol dependence	0.00667	0.0415	CbGbCtD
Buprenorphine—CYP2C19—Citalopram—alcohol dependence	0.00571	0.0356	CbGbCtD
Buprenorphine—CYP1A2—Citalopram—alcohol dependence	0.00527	0.0328	CbGbCtD
Buprenorphine—ABCB1—Citalopram—alcohol dependence	0.00461	0.0287	CbGbCtD
Buprenorphine—CYP2D6—Citalopram—alcohol dependence	0.00434	0.0271	CbGbCtD
Buprenorphine—CYP3A4—Disulfiram—alcohol dependence	0.00388	0.0241	CbGbCtD
Buprenorphine—CYP3A4—Citalopram—alcohol dependence	0.00276	0.0172	CbGbCtD
Buprenorphine—OPRL1—brainstem—alcohol dependence	0.00055	0.0495	CbGeAlD
Buprenorphine—OPRL1—forebrain—alcohol dependence	0.000531	0.0478	CbGeAlD
Buprenorphine—OPRM1—nerve—alcohol dependence	0.00045	0.0405	CbGeAlD
Buprenorphine—OPRL1—blood—alcohol dependence	0.000355	0.032	CbGeAlD
Buprenorphine—OPRL1—endocrine gland—alcohol dependence	0.000308	0.0277	CbGeAlD
Buprenorphine—OPRL1—testis—alcohol dependence	0.000294	0.0264	CbGeAlD
Buprenorphine—OPRL1—nervous system—alcohol dependence	0.000288	0.0259	CbGeAlD
Buprenorphine—OPRL1—central nervous system—alcohol dependence	0.000278	0.025	CbGeAlD
Buprenorphine—OPRD1—forebrain—alcohol dependence	0.000274	0.0246	CbGeAlD
Buprenorphine—OPRK1—forebrain—alcohol dependence	0.000262	0.0236	CbGeAlD
Buprenorphine—UGT1A9—digestive system—alcohol dependence	0.000243	0.0219	CbGeAlD
Buprenorphine—OPRL1—brain—alcohol dependence	0.00022	0.0198	CbGeAlD
Buprenorphine—Methylnaltrexone—OPRK1—alcohol dependence	0.000219	0.0961	CrCbGaD
Buprenorphine—Butorphanol—OPRK1—alcohol dependence	0.000219	0.0961	CrCbGaD
Buprenorphine—CYP2C18—digestive system—alcohol dependence	0.000212	0.0191	CbGeAlD
Buprenorphine—UGT1A9—endocrine gland—alcohol dependence	0.000201	0.0181	CbGeAlD
Buprenorphine—Nalbuphine—OPRK1—alcohol dependence	0.000201	0.0879	CrCbGaD
Buprenorphine—OPRM1—brainstem—alcohol dependence	0.000193	0.0174	CbGeAlD
Buprenorphine—OPRM1—forebrain—alcohol dependence	0.000187	0.0168	CbGeAlD
Buprenorphine—UGT1A9—liver—alcohol dependence	0.000181	0.0163	CbGeAlD
Buprenorphine—CYP2C18—endocrine gland—alcohol dependence	0.000176	0.0158	CbGeAlD
Buprenorphine—CYP3A7—endocrine gland—alcohol dependence	0.000167	0.015	CbGeAlD
Buprenorphine—Oxymorphone—OPRK1—alcohol dependence	0.000163	0.0717	CrCbGaD
Buprenorphine—Naltrexone—OPRK1—alcohol dependence	0.000163	0.0717	CrCbGaD
Buprenorphine—CYP2C18—liver—alcohol dependence	0.000158	0.0142	CbGeAlD
Buprenorphine—Butorphanol—OPRD1—alcohol dependence	0.000154	0.0677	CrCbGaD
Buprenorphine—CYP3A7—liver—alcohol dependence	0.000151	0.0135	CbGeAlD
Buprenorphine—OPRD1—nervous system—alcohol dependence	0.000149	0.0134	CbGeAlD
Buprenorphine—OPRD1—central nervous system—alcohol dependence	0.000143	0.0129	CbGeAlD
Buprenorphine—OPRK1—nervous system—alcohol dependence	0.000142	0.0128	CbGeAlD
Buprenorphine—Nalbuphine—OPRD1—alcohol dependence	0.000141	0.062	CrCbGaD
Buprenorphine—OPRK1—central nervous system—alcohol dependence	0.000137	0.0123	CbGeAlD
Buprenorphine—OPRK1—cerebellum—alcohol dependence	0.000134	0.0121	CbGeAlD
Buprenorphine—CYP3A7-CYP3A51P—liver—alcohol dependence	0.000128	0.0115	CbGeAlD
Buprenorphine—OPRM1—blood—alcohol dependence	0.000125	0.0112	CbGeAlD
Buprenorphine—OPRM1—midbrain—alcohol dependence	0.000123	0.0111	CbGeAlD
Buprenorphine—Naloxone—OPRK1—alcohol dependence	0.000119	0.0523	CrCbGaD
Buprenorphine—Butorphanol—OPRM1—alcohol dependence	0.000118	0.0518	CrCbGaD
Buprenorphine—Methylnaltrexone—OPRM1—alcohol dependence	0.000118	0.0518	CrCbGaD
Buprenorphine—Naltrexone—OPRD1—alcohol dependence	0.000115	0.0505	CrCbGaD
Buprenorphine—Oxymorphone—OPRD1—alcohol dependence	0.000115	0.0505	CrCbGaD
Buprenorphine—OPRD1—brain—alcohol dependence	0.000114	0.0102	CbGeAlD
Buprenorphine—OPRK1—brain—alcohol dependence	0.000109	0.0098	CbGeAlD
Buprenorphine—OPRM1—endocrine gland—alcohol dependence	0.000108	0.00974	CbGeAlD
Buprenorphine—Nalbuphine—OPRM1—alcohol dependence	0.000108	0.0474	CrCbGaD
Buprenorphine—CYP2A6—liver—alcohol dependence	0.000105	0.00941	CbGeAlD
Buprenorphine—OPRM1—testis—alcohol dependence	0.000103	0.00929	CbGeAlD
Buprenorphine—CYP2A6—cerebellum—alcohol dependence	0.000102	0.00919	CbGeAlD
Buprenorphine—OPRM1—nervous system—alcohol dependence	0.000101	0.00912	CbGeAlD
Buprenorphine—ABCG2—adrenal cortex—alcohol dependence	0.000101	0.0091	CbGeAlD
Buprenorphine—OPRM1—central nervous system—alcohol dependence	9.75e-05	0.00878	CbGeAlD
Buprenorphine—CYP2C19—digestive system—alcohol dependence	9.03e-05	0.00812	CbGeAlD
Buprenorphine—Naltrexone—OPRM1—alcohol dependence	8.81e-05	0.0386	CrCbGaD
Buprenorphine—Oxymorphone—OPRM1—alcohol dependence	8.81e-05	0.0386	CrCbGaD
Buprenorphine—CYP2C19—blood—alcohol dependence	8.6e-05	0.00774	CbGeAlD
Buprenorphine—CYP2C9—cardiovascular system—alcohol dependence	8.43e-05	0.00759	CbGeAlD
Buprenorphine—Naloxone—OPRD1—alcohol dependence	8.4e-05	0.0368	CrCbGaD
Buprenorphine—CYP3A5—pancreas—alcohol dependence	8.33e-05	0.00749	CbGeAlD
Buprenorphine—Tinnitus—Naltrexone—alcohol dependence	8.3e-05	0.00186	CcSEcCtD
Buprenorphine—CYP2A6—brain—alcohol dependence	8.3e-05	0.00747	CbGeAlD
Buprenorphine—Cardiac disorder—Naltrexone—alcohol dependence	8.26e-05	0.00185	CcSEcCtD
Buprenorphine—Mental disorder—Acamprosate—alcohol dependence	8.24e-05	0.00185	CcSEcCtD
Buprenorphine—Malnutrition—Acamprosate—alcohol dependence	8.19e-05	0.00184	CcSEcCtD
Buprenorphine—Pain in extremity—Citalopram—alcohol dependence	8.15e-05	0.00183	CcSEcCtD
Buprenorphine—Diplopia—Citalopram—alcohol dependence	8.15e-05	0.00183	CcSEcCtD
Buprenorphine—Osteoarthritis—Citalopram—alcohol dependence	8.15e-05	0.00183	CcSEcCtD
Buprenorphine—Disturbance in sexual arousal—Citalopram—alcohol dependence	8.09e-05	0.00181	CcSEcCtD
Buprenorphine—Angiopathy—Naltrexone—alcohol dependence	8.07e-05	0.00181	CcSEcCtD
Buprenorphine—Flatulence—Acamprosate—alcohol dependence	8.07e-05	0.00181	CcSEcCtD
Buprenorphine—Immune system disorder—Naltrexone—alcohol dependence	8.04e-05	0.0018	CcSEcCtD
Buprenorphine—Tension—Acamprosate—alcohol dependence	8.04e-05	0.0018	CcSEcCtD
Buprenorphine—Affect lability—Citalopram—alcohol dependence	8.02e-05	0.0018	CcSEcCtD
Buprenorphine—Migraine—Citalopram—alcohol dependence	8.02e-05	0.0018	CcSEcCtD
Buprenorphine—Mediastinal disorder—Naltrexone—alcohol dependence	8.02e-05	0.0018	CcSEcCtD
Buprenorphine—Dysgeusia—Acamprosate—alcohol dependence	8.02e-05	0.0018	CcSEcCtD
Buprenorphine—Chills—Naltrexone—alcohol dependence	7.99e-05	0.00179	CcSEcCtD
Buprenorphine—Psychotic disorder—Citalopram—alcohol dependence	7.96e-05	0.00179	CcSEcCtD
Buprenorphine—Nervousness—Acamprosate—alcohol dependence	7.95e-05	0.00178	CcSEcCtD
Buprenorphine—Back pain—Acamprosate—alcohol dependence	7.92e-05	0.00178	CcSEcCtD
Buprenorphine—Muscle spasms—Acamprosate—alcohol dependence	7.87e-05	0.00177	CcSEcCtD
Buprenorphine—Face oedema—Citalopram—alcohol dependence	7.87e-05	0.00177	CcSEcCtD
Buprenorphine—Mental disorder—Naltrexone—alcohol dependence	7.8e-05	0.00175	CcSEcCtD
Buprenorphine—CYP2D6—brainstem—alcohol dependence	7.75e-05	0.00698	CbGeAlD
Buprenorphine—Urinary retention—Citalopram—alcohol dependence	7.75e-05	0.00174	CcSEcCtD
Buprenorphine—Malnutrition—Naltrexone—alcohol dependence	7.75e-05	0.00174	CcSEcCtD
Buprenorphine—OPRM1—brain—alcohol dependence	7.74e-05	0.00697	CbGeAlD
Buprenorphine—Mood swings—Citalopram—alcohol dependence	7.72e-05	0.00173	CcSEcCtD
Buprenorphine—Tremor—Acamprosate—alcohol dependence	7.67e-05	0.00172	CcSEcCtD
Buprenorphine—Flatulence—Naltrexone—alcohol dependence	7.63e-05	0.00171	CcSEcCtD
Buprenorphine—Tension—Naltrexone—alcohol dependence	7.6e-05	0.00171	CcSEcCtD
Buprenorphine—Ill-defined disorder—Acamprosate—alcohol dependence	7.6e-05	0.0017	CcSEcCtD
Buprenorphine—Dysgeusia—Naltrexone—alcohol dependence	7.59e-05	0.0017	CcSEcCtD
Buprenorphine—Dehydration—Citalopram—alcohol dependence	7.58e-05	0.0017	CcSEcCtD
Buprenorphine—Agitation—Acamprosate—alcohol dependence	7.53e-05	0.00169	CcSEcCtD
Buprenorphine—Nervousness—Naltrexone—alcohol dependence	7.52e-05	0.00169	CcSEcCtD
Buprenorphine—CYP2C8—blood—alcohol dependence	7.51e-05	0.00675	CbGeAlD
Buprenorphine—Back pain—Naltrexone—alcohol dependence	7.49e-05	0.00168	CcSEcCtD
Buprenorphine—CYP2D6—forebrain—alcohol dependence	7.48e-05	0.00673	CbGeAlD
Buprenorphine—Angioedema—Acamprosate—alcohol dependence	7.48e-05	0.00168	CcSEcCtD
Buprenorphine—Dry skin—Citalopram—alcohol dependence	7.47e-05	0.00168	CcSEcCtD
Buprenorphine—CYP2C19—endocrine gland—alcohol dependence	7.46e-05	0.00671	CbGeAlD
Buprenorphine—Muscle spasms—Naltrexone—alcohol dependence	7.45e-05	0.00167	CcSEcCtD
Buprenorphine—Orthostatic hypotension—Citalopram—alcohol dependence	7.45e-05	0.00167	CcSEcCtD
Buprenorphine—Abdominal pain upper—Citalopram—alcohol dependence	7.45e-05	0.00167	CcSEcCtD
Buprenorphine—Malaise—Acamprosate—alcohol dependence	7.38e-05	0.00166	CcSEcCtD
Buprenorphine—CYP1A2—digestive system—alcohol dependence	7.37e-05	0.00663	CbGeAlD
Buprenorphine—Breast disorder—Citalopram—alcohol dependence	7.37e-05	0.00165	CcSEcCtD
Buprenorphine—Vertigo—Acamprosate—alcohol dependence	7.36e-05	0.00165	CcSEcCtD
Buprenorphine—Syncope—Acamprosate—alcohol dependence	7.34e-05	0.00165	CcSEcCtD
Buprenorphine—Cramp muscle—Citalopram—alcohol dependence	7.34e-05	0.00165	CcSEcCtD
Buprenorphine—Vision blurred—Naltrexone—alcohol dependence	7.3e-05	0.00164	CcSEcCtD
Buprenorphine—ABCG2—blood—alcohol dependence	7.3e-05	0.00657	CbGeAlD
Buprenorphine—Nasopharyngitis—Citalopram—alcohol dependence	7.29e-05	0.00164	CcSEcCtD
Buprenorphine—Tremor—Naltrexone—alcohol dependence	7.26e-05	0.00163	CcSEcCtD
Buprenorphine—Palpitations—Acamprosate—alcohol dependence	7.24e-05	0.00162	CcSEcCtD
Buprenorphine—ABCG2—midbrain—alcohol dependence	7.21e-05	0.00649	CbGeAlD
Buprenorphine—Loss of consciousness—Acamprosate—alcohol dependence	7.2e-05	0.00161	CcSEcCtD
Buprenorphine—Muscular weakness—Citalopram—alcohol dependence	7.19e-05	0.00161	CcSEcCtD
Buprenorphine—Alanine aminotransferase increased—Citalopram—alcohol dependence	7.19e-05	0.00161	CcSEcCtD
Buprenorphine—Ill-defined disorder—Naltrexone—alcohol dependence	7.19e-05	0.00161	CcSEcCtD
Buprenorphine—Cough—Acamprosate—alcohol dependence	7.15e-05	0.0016	CcSEcCtD
Buprenorphine—Agitation—Naltrexone—alcohol dependence	7.12e-05	0.0016	CcSEcCtD
Buprenorphine—CYP3A5—digestive system—alcohol dependence	7.11e-05	0.0064	CbGeAlD
Buprenorphine—Convulsion—Acamprosate—alcohol dependence	7.09e-05	0.00159	CcSEcCtD
Buprenorphine—Abdominal distension—Citalopram—alcohol dependence	7.09e-05	0.00159	CcSEcCtD
Buprenorphine—Angioedema—Naltrexone—alcohol dependence	7.08e-05	0.00159	CcSEcCtD
Buprenorphine—Hypertension—Acamprosate—alcohol dependence	7.07e-05	0.00159	CcSEcCtD
Buprenorphine—Asthma—Citalopram—alcohol dependence	7.05e-05	0.00158	CcSEcCtD
Buprenorphine—Influenza—Citalopram—alcohol dependence	7.05e-05	0.00158	CcSEcCtD
Buprenorphine—Dysphagia—Citalopram—alcohol dependence	7.05e-05	0.00158	CcSEcCtD
Buprenorphine—CYP1A2—blood—alcohol dependence	7.02e-05	0.00632	CbGeAlD
Buprenorphine—CYP2C9—digestive system—alcohol dependence	7e-05	0.0063	CbGeAlD
Buprenorphine—Malaise—Naltrexone—alcohol dependence	6.99e-05	0.00157	CcSEcCtD
Buprenorphine—Myalgia—Acamprosate—alcohol dependence	6.97e-05	0.00156	CcSEcCtD
Buprenorphine—Chest pain—Acamprosate—alcohol dependence	6.97e-05	0.00156	CcSEcCtD
Buprenorphine—Arthralgia—Acamprosate—alcohol dependence	6.97e-05	0.00156	CcSEcCtD
Buprenorphine—Syncope—Naltrexone—alcohol dependence	6.95e-05	0.00156	CcSEcCtD
Buprenorphine—Anxiety—Acamprosate—alcohol dependence	6.95e-05	0.00156	CcSEcCtD
Buprenorphine—Bronchospasm—Citalopram—alcohol dependence	6.93e-05	0.00155	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	6.92e-05	0.00155	CcSEcCtD
Buprenorphine—Discomfort—Acamprosate—alcohol dependence	6.89e-05	0.00155	CcSEcCtD
Buprenorphine—Angina pectoris—Citalopram—alcohol dependence	6.86e-05	0.00154	CcSEcCtD
Buprenorphine—Palpitations—Naltrexone—alcohol dependence	6.85e-05	0.00154	CcSEcCtD
Buprenorphine—Dry mouth—Acamprosate—alcohol dependence	6.82e-05	0.00153	CcSEcCtD
Buprenorphine—Loss of consciousness—Naltrexone—alcohol dependence	6.81e-05	0.00153	CcSEcCtD
Buprenorphine—Bronchitis—Citalopram—alcohol dependence	6.78e-05	0.00152	CcSEcCtD
Buprenorphine—CYP3A5—blood—alcohol dependence	6.78e-05	0.0061	CbGeAlD
Buprenorphine—Cough—Naltrexone—alcohol dependence	6.76e-05	0.00152	CcSEcCtD
Buprenorphine—Abdominal discomfort—Citalopram—alcohol dependence	6.75e-05	0.00152	CcSEcCtD
Buprenorphine—Confusional state—Acamprosate—alcohol dependence	6.74e-05	0.00151	CcSEcCtD
Buprenorphine—CYP2C19—liver—alcohol dependence	6.73e-05	0.00605	CbGeAlD
Buprenorphine—Convulsion—Naltrexone—alcohol dependence	6.71e-05	0.00151	CcSEcCtD
Buprenorphine—Hypertension—Naltrexone—alcohol dependence	6.69e-05	0.0015	CcSEcCtD
Buprenorphine—Anaphylactic shock—Acamprosate—alcohol dependence	6.68e-05	0.0015	CcSEcCtD
Buprenorphine—CYP2C9—blood—alcohol dependence	6.67e-05	0.006	CbGeAlD
Buprenorphine—Infection—Acamprosate—alcohol dependence	6.64e-05	0.00149	CcSEcCtD
Buprenorphine—Arthralgia—Naltrexone—alcohol dependence	6.6e-05	0.00148	CcSEcCtD
Buprenorphine—Myalgia—Naltrexone—alcohol dependence	6.6e-05	0.00148	CcSEcCtD
Buprenorphine—Chest pain—Naltrexone—alcohol dependence	6.6e-05	0.00148	CcSEcCtD
Buprenorphine—Shock—Acamprosate—alcohol dependence	6.58e-05	0.00147	CcSEcCtD
Buprenorphine—Anxiety—Naltrexone—alcohol dependence	6.57e-05	0.00147	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	6.55e-05	0.00147	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Citalopram—alcohol dependence	6.55e-05	0.00147	CcSEcCtD
Buprenorphine—Tachycardia—Acamprosate—alcohol dependence	6.52e-05	0.00146	CcSEcCtD
Buprenorphine—Discomfort—Naltrexone—alcohol dependence	6.52e-05	0.00146	CcSEcCtD
Buprenorphine—CYP2C8—endocrine gland—alcohol dependence	6.51e-05	0.00586	CbGeAlD
Buprenorphine—Skin disorder—Acamprosate—alcohol dependence	6.49e-05	0.00146	CcSEcCtD
Buprenorphine—Hyperhidrosis—Acamprosate—alcohol dependence	6.46e-05	0.00145	CcSEcCtD
Buprenorphine—Dry mouth—Naltrexone—alcohol dependence	6.45e-05	0.00145	CcSEcCtD
Buprenorphine—Naloxone—OPRM1—alcohol dependence	6.43e-05	0.0282	CrCbGaD
Buprenorphine—Confusional state—Naltrexone—alcohol dependence	6.38e-05	0.00143	CcSEcCtD
Buprenorphine—Weight decreased—Citalopram—alcohol dependence	6.37e-05	0.00143	CcSEcCtD
Buprenorphine—Anorexia—Acamprosate—alcohol dependence	6.37e-05	0.00143	CcSEcCtD
Buprenorphine—Oedema—Naltrexone—alcohol dependence	6.32e-05	0.00142	CcSEcCtD
Buprenorphine—Anaphylactic shock—Naltrexone—alcohol dependence	6.32e-05	0.00142	CcSEcCtD
Buprenorphine—Infection—Naltrexone—alcohol dependence	6.28e-05	0.00141	CcSEcCtD
Buprenorphine—Infestation—Citalopram—alcohol dependence	6.28e-05	0.00141	CcSEcCtD
Buprenorphine—Infestation NOS—Citalopram—alcohol dependence	6.28e-05	0.00141	CcSEcCtD
Buprenorphine—Depression—Citalopram—alcohol dependence	6.26e-05	0.00141	CcSEcCtD
Buprenorphine—Hypotension—Acamprosate—alcohol dependence	6.24e-05	0.0014	CcSEcCtD
Buprenorphine—Shock—Naltrexone—alcohol dependence	6.22e-05	0.0014	CcSEcCtD
Buprenorphine—CYP2C8—testis—alcohol dependence	6.21e-05	0.00559	CbGeAlD
Buprenorphine—Nervous system disorder—Naltrexone—alcohol dependence	6.2e-05	0.00139	CcSEcCtD
Buprenorphine—Tachycardia—Naltrexone—alcohol dependence	6.17e-05	0.00138	CcSEcCtD
Buprenorphine—Skin disorder—Naltrexone—alcohol dependence	6.14e-05	0.00138	CcSEcCtD
Buprenorphine—Hyperhidrosis—Naltrexone—alcohol dependence	6.11e-05	0.00137	CcSEcCtD
Buprenorphine—Conjunctivitis—Citalopram—alcohol dependence	6.11e-05	0.00137	CcSEcCtD
Buprenorphine—Urinary tract infection—Citalopram—alcohol dependence	6.11e-05	0.00137	CcSEcCtD
Buprenorphine—CYP1A2—endocrine gland—alcohol dependence	6.09e-05	0.00548	CbGeAlD
Buprenorphine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	6.09e-05	0.00137	CcSEcCtD
Buprenorphine—Insomnia—Acamprosate—alcohol dependence	6.04e-05	0.00136	CcSEcCtD
Buprenorphine—ABCG2—testis—alcohol dependence	6.04e-05	0.00543	CbGeAlD
Buprenorphine—Anorexia—Naltrexone—alcohol dependence	6.03e-05	0.00135	CcSEcCtD
Buprenorphine—Sweating—Citalopram—alcohol dependence	6.02e-05	0.00135	CcSEcCtD
Buprenorphine—Paraesthesia—Acamprosate—alcohol dependence	6e-05	0.00135	CcSEcCtD
Buprenorphine—Dyspnoea—Acamprosate—alcohol dependence	5.96e-05	0.00134	CcSEcCtD
Buprenorphine—Somnolence—Acamprosate—alcohol dependence	5.94e-05	0.00133	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Citalopram—alcohol dependence	5.94e-05	0.00133	CcSEcCtD
Buprenorphine—Sinusitis—Citalopram—alcohol dependence	5.89e-05	0.00132	CcSEcCtD
Buprenorphine—Dyspepsia—Acamprosate—alcohol dependence	5.88e-05	0.00132	CcSEcCtD
Buprenorphine—CYP3A5—endocrine gland—alcohol dependence	5.88e-05	0.00529	CbGeAlD
Buprenorphine—CYP2C8—liver—alcohol dependence	5.87e-05	0.00528	CbGeAlD
Buprenorphine—Decreased appetite—Acamprosate—alcohol dependence	5.81e-05	0.0013	CcSEcCtD
Buprenorphine—CYP2C9—endocrine gland—alcohol dependence	5.78e-05	0.0052	CbGeAlD
Buprenorphine—Gastrointestinal disorder—Acamprosate—alcohol dependence	5.77e-05	0.00129	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	5.76e-05	0.00129	CcSEcCtD
Buprenorphine—Bradycardia—Citalopram—alcohol dependence	5.74e-05	0.00129	CcSEcCtD
Buprenorphine—Insomnia—Naltrexone—alcohol dependence	5.72e-05	0.00128	CcSEcCtD
Buprenorphine—Constipation—Acamprosate—alcohol dependence	5.72e-05	0.00128	CcSEcCtD
Buprenorphine—Pain—Acamprosate—alcohol dependence	5.72e-05	0.00128	CcSEcCtD
Buprenorphine—ABCG2—liver—alcohol dependence	5.71e-05	0.00514	CbGeAlD
Buprenorphine—Paraesthesia—Naltrexone—alcohol dependence	5.68e-05	0.00127	CcSEcCtD
Buprenorphine—Rhinitis—Citalopram—alcohol dependence	5.65e-05	0.00127	CcSEcCtD
Buprenorphine—Dyspnoea—Naltrexone—alcohol dependence	5.64e-05	0.00126	CcSEcCtD
Buprenorphine—Somnolence—Naltrexone—alcohol dependence	5.62e-05	0.00126	CcSEcCtD
Buprenorphine—Hypoaesthesia—Citalopram—alcohol dependence	5.61e-05	0.00126	CcSEcCtD
Buprenorphine—Hallucination—Citalopram—alcohol dependence	5.61e-05	0.00126	CcSEcCtD
Buprenorphine—Pharyngitis—Citalopram—alcohol dependence	5.6e-05	0.00126	CcSEcCtD
Buprenorphine—ABCG2—cerebellum—alcohol dependence	5.58e-05	0.00502	CbGeAlD
Buprenorphine—Urinary tract disorder—Citalopram—alcohol dependence	5.57e-05	0.00125	CcSEcCtD
Buprenorphine—Oedema peripheral—Citalopram—alcohol dependence	5.56e-05	0.00125	CcSEcCtD
Buprenorphine—Connective tissue disorder—Citalopram—alcohol dependence	5.54e-05	0.00124	CcSEcCtD
Buprenorphine—Urethral disorder—Citalopram—alcohol dependence	5.53e-05	0.00124	CcSEcCtD
Buprenorphine—Feeling abnormal—Acamprosate—alcohol dependence	5.51e-05	0.00124	CcSEcCtD
Buprenorphine—Decreased appetite—Naltrexone—alcohol dependence	5.5e-05	0.00123	CcSEcCtD
Buprenorphine—CYP1A2—liver—alcohol dependence	5.49e-05	0.00494	CbGeAlD
Buprenorphine—Gastrointestinal pain—Acamprosate—alcohol dependence	5.46e-05	0.00123	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Naltrexone—alcohol dependence	5.46e-05	0.00122	CcSEcCtD
Buprenorphine—Fatigue—Naltrexone—alcohol dependence	5.45e-05	0.00122	CcSEcCtD
Buprenorphine—Visual impairment—Citalopram—alcohol dependence	5.43e-05	0.00122	CcSEcCtD
Buprenorphine—Constipation—Naltrexone—alcohol dependence	5.41e-05	0.00121	CcSEcCtD
Buprenorphine—Pain—Naltrexone—alcohol dependence	5.41e-05	0.00121	CcSEcCtD
Buprenorphine—ABCB1—forebrain—alcohol dependence	5.38e-05	0.00484	CbGeAlD
Buprenorphine—CYP3A4—digestive system—alcohol dependence	5.34e-05	0.0048	CbGeAlD
Buprenorphine—Urticaria—Acamprosate—alcohol dependence	5.31e-05	0.00119	CcSEcCtD
Buprenorphine—CYP3A5—liver—alcohol dependence	5.3e-05	0.00477	CbGeAlD
Buprenorphine—Body temperature increased—Acamprosate—alcohol dependence	5.28e-05	0.00119	CcSEcCtD
Buprenorphine—Abdominal pain—Acamprosate—alcohol dependence	5.28e-05	0.00119	CcSEcCtD
Buprenorphine—Eye disorder—Citalopram—alcohol dependence	5.27e-05	0.00118	CcSEcCtD
Buprenorphine—Tinnitus—Citalopram—alcohol dependence	5.26e-05	0.00118	CcSEcCtD
Buprenorphine—CYP2D6—digestive system—alcohol dependence	5.25e-05	0.00473	CbGeAlD
Buprenorphine—Flushing—Citalopram—alcohol dependence	5.23e-05	0.00117	CcSEcCtD
Buprenorphine—Cardiac disorder—Citalopram—alcohol dependence	5.23e-05	0.00117	CcSEcCtD
Buprenorphine—CYP2C9—liver—alcohol dependence	5.21e-05	0.00469	CbGeAlD
Buprenorphine—Feeling abnormal—Naltrexone—alcohol dependence	5.21e-05	0.00117	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Naltrexone—alcohol dependence	5.17e-05	0.00116	CcSEcCtD
Buprenorphine—Angiopathy—Citalopram—alcohol dependence	5.12e-05	0.00115	CcSEcCtD
Buprenorphine—Immune system disorder—Citalopram—alcohol dependence	5.09e-05	0.00114	CcSEcCtD
Buprenorphine—CYP3A4—blood—alcohol dependence	5.08e-05	0.00458	CbGeAlD
Buprenorphine—Mediastinal disorder—Citalopram—alcohol dependence	5.08e-05	0.00114	CcSEcCtD
Buprenorphine—Chills—Citalopram—alcohol dependence	5.06e-05	0.00114	CcSEcCtD
Buprenorphine—Urticaria—Naltrexone—alcohol dependence	5.02e-05	0.00113	CcSEcCtD
Buprenorphine—CYP2D6—blood—alcohol dependence	5e-05	0.0045	CbGeAlD
Buprenorphine—Body temperature increased—Naltrexone—alcohol dependence	5e-05	0.00112	CcSEcCtD
Buprenorphine—Abdominal pain—Naltrexone—alcohol dependence	5e-05	0.00112	CcSEcCtD
Buprenorphine—ABCB1—adrenal cortex—alcohol dependence	4.99e-05	0.00449	CbGeAlD
Buprenorphine—Mental disorder—Citalopram—alcohol dependence	4.94e-05	0.00111	CcSEcCtD
Buprenorphine—Hypersensitivity—Acamprosate—alcohol dependence	4.92e-05	0.0011	CcSEcCtD
Buprenorphine—Erythema—Citalopram—alcohol dependence	4.91e-05	0.0011	CcSEcCtD
Buprenorphine—Malnutrition—Citalopram—alcohol dependence	4.91e-05	0.0011	CcSEcCtD
Buprenorphine—Flatulence—Citalopram—alcohol dependence	4.84e-05	0.00109	CcSEcCtD
Buprenorphine—Tension—Citalopram—alcohol dependence	4.82e-05	0.00108	CcSEcCtD
Buprenorphine—Dysgeusia—Citalopram—alcohol dependence	4.81e-05	0.00108	CcSEcCtD
Buprenorphine—Asthenia—Acamprosate—alcohol dependence	4.8e-05	0.00108	CcSEcCtD
Buprenorphine—Nervousness—Citalopram—alcohol dependence	4.77e-05	0.00107	CcSEcCtD
Buprenorphine—Back pain—Citalopram—alcohol dependence	4.75e-05	0.00107	CcSEcCtD
Buprenorphine—Pruritus—Acamprosate—alcohol dependence	4.73e-05	0.00106	CcSEcCtD
Buprenorphine—Muscle spasms—Citalopram—alcohol dependence	4.72e-05	0.00106	CcSEcCtD
Buprenorphine—Hypersensitivity—Naltrexone—alcohol dependence	4.66e-05	0.00105	CcSEcCtD
Buprenorphine—CYP2C8—brain—alcohol dependence	4.66e-05	0.00419	CbGeAlD
Buprenorphine—Vision blurred—Citalopram—alcohol dependence	4.63e-05	0.00104	CcSEcCtD
Buprenorphine—Tremor—Citalopram—alcohol dependence	4.6e-05	0.00103	CcSEcCtD
Buprenorphine—Diarrhoea—Acamprosate—alcohol dependence	4.57e-05	0.00103	CcSEcCtD
Buprenorphine—Ill-defined disorder—Citalopram—alcohol dependence	4.55e-05	0.00102	CcSEcCtD
Buprenorphine—ABCB1—cardiovascular system—alcohol dependence	4.55e-05	0.0041	CbGeAlD
Buprenorphine—Asthenia—Naltrexone—alcohol dependence	4.54e-05	0.00102	CcSEcCtD
Buprenorphine—ABCG2—brain—alcohol dependence	4.53e-05	0.00408	CbGeAlD
Buprenorphine—Agitation—Citalopram—alcohol dependence	4.51e-05	0.00101	CcSEcCtD
Buprenorphine—Angioedema—Citalopram—alcohol dependence	4.49e-05	0.00101	CcSEcCtD
Buprenorphine—Pruritus—Naltrexone—alcohol dependence	4.47e-05	0.001	CcSEcCtD
Buprenorphine—Malaise—Citalopram—alcohol dependence	4.43e-05	0.000993	CcSEcCtD
Buprenorphine—ABCB1—pancreas—alcohol dependence	4.42e-05	0.00398	CbGeAlD
Buprenorphine—Dizziness—Acamprosate—alcohol dependence	4.42e-05	0.000991	CcSEcCtD
Buprenorphine—Vertigo—Citalopram—alcohol dependence	4.41e-05	0.000989	CcSEcCtD
Buprenorphine—CYP3A4—endocrine gland—alcohol dependence	4.41e-05	0.00397	CbGeAlD
Buprenorphine—Syncope—Citalopram—alcohol dependence	4.4e-05	0.000988	CcSEcCtD
Buprenorphine—CYP2D6—endocrine gland—alcohol dependence	4.34e-05	0.00391	CbGeAlD
Buprenorphine—Palpitations—Citalopram—alcohol dependence	4.34e-05	0.000973	CcSEcCtD
Buprenorphine—Diarrhoea—Naltrexone—alcohol dependence	4.33e-05	0.00097	CcSEcCtD
Buprenorphine—Loss of consciousness—Citalopram—alcohol dependence	4.31e-05	0.000968	CcSEcCtD
Buprenorphine—Cough—Citalopram—alcohol dependence	4.28e-05	0.000961	CcSEcCtD
Buprenorphine—Convulsion—Citalopram—alcohol dependence	4.25e-05	0.000954	CcSEcCtD
Buprenorphine—Vomiting—Acamprosate—alcohol dependence	4.25e-05	0.000953	CcSEcCtD
Buprenorphine—Hypertension—Citalopram—alcohol dependence	4.24e-05	0.000951	CcSEcCtD
Buprenorphine—Rash—Acamprosate—alcohol dependence	4.21e-05	0.000945	CcSEcCtD
Buprenorphine—Dermatitis—Acamprosate—alcohol dependence	4.21e-05	0.000944	CcSEcCtD
Buprenorphine—Headache—Acamprosate—alcohol dependence	4.19e-05	0.000939	CcSEcCtD
Buprenorphine—Dizziness—Naltrexone—alcohol dependence	4.18e-05	0.000938	CcSEcCtD
Buprenorphine—Chest pain—Citalopram—alcohol dependence	4.18e-05	0.000937	CcSEcCtD
Buprenorphine—Arthralgia—Citalopram—alcohol dependence	4.18e-05	0.000937	CcSEcCtD
Buprenorphine—Myalgia—Citalopram—alcohol dependence	4.18e-05	0.000937	CcSEcCtD
Buprenorphine—Anxiety—Citalopram—alcohol dependence	4.16e-05	0.000934	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	4.15e-05	0.000931	CcSEcCtD
Buprenorphine—CYP2D6—testis—alcohol dependence	4.14e-05	0.00372	CbGeAlD
Buprenorphine—ABCB1—gonad—alcohol dependence	4.13e-05	0.00372	CbGeAlD
Buprenorphine—Discomfort—Citalopram—alcohol dependence	4.13e-05	0.000926	CcSEcCtD
Buprenorphine—CYP3A4—nervous system—alcohol dependence	4.13e-05	0.00371	CbGeAlD
Buprenorphine—Dry mouth—Citalopram—alcohol dependence	4.09e-05	0.000917	CcSEcCtD
Buprenorphine—CYP2D6—nervous system—alcohol dependence	4.06e-05	0.00366	CbGeAlD
Buprenorphine—Confusional state—Citalopram—alcohol dependence	4.04e-05	0.000906	CcSEcCtD
Buprenorphine—Vomiting—Naltrexone—alcohol dependence	4.02e-05	0.000902	CcSEcCtD
Buprenorphine—Oedema—Citalopram—alcohol dependence	4.01e-05	0.000899	CcSEcCtD
Buprenorphine—Anaphylactic shock—Citalopram—alcohol dependence	4.01e-05	0.000899	CcSEcCtD
Buprenorphine—Rash—Naltrexone—alcohol dependence	3.99e-05	0.000894	CcSEcCtD
Buprenorphine—Dermatitis—Naltrexone—alcohol dependence	3.98e-05	0.000893	CcSEcCtD
Buprenorphine—Infection—Citalopram—alcohol dependence	3.98e-05	0.000893	CcSEcCtD
Buprenorphine—CYP3A4—liver—alcohol dependence	3.98e-05	0.00358	CbGeAlD
Buprenorphine—CYP3A4—central nervous system—alcohol dependence	3.97e-05	0.00358	CbGeAlD
Buprenorphine—Nausea—Acamprosate—alcohol dependence	3.97e-05	0.00089	CcSEcCtD
Buprenorphine—Headache—Naltrexone—alcohol dependence	3.96e-05	0.000889	CcSEcCtD
Buprenorphine—Shock—Citalopram—alcohol dependence	3.94e-05	0.000884	CcSEcCtD
Buprenorphine—Nervous system disorder—Citalopram—alcohol dependence	3.93e-05	0.000881	CcSEcCtD
Buprenorphine—CYP2D6—liver—alcohol dependence	3.91e-05	0.00352	CbGeAlD
Buprenorphine—CYP2D6—central nervous system—alcohol dependence	3.91e-05	0.00352	CbGeAlD
Buprenorphine—Tachycardia—Citalopram—alcohol dependence	3.91e-05	0.000877	CcSEcCtD
Buprenorphine—Skin disorder—Citalopram—alcohol dependence	3.89e-05	0.000873	CcSEcCtD
Buprenorphine—Hyperhidrosis—Citalopram—alcohol dependence	3.87e-05	0.000869	CcSEcCtD
Buprenorphine—CYP2D6—cerebellum—alcohol dependence	3.82e-05	0.00344	CbGeAlD
Buprenorphine—Anorexia—Citalopram—alcohol dependence	3.82e-05	0.000857	CcSEcCtD
Buprenorphine—ABCB1—digestive system—alcohol dependence	3.78e-05	0.0034	CbGeAlD
Buprenorphine—Nausea—Naltrexone—alcohol dependence	3.76e-05	0.000843	CcSEcCtD
Buprenorphine—Hypotension—Citalopram—alcohol dependence	3.74e-05	0.00084	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Citalopram—alcohol dependence	3.65e-05	0.000819	CcSEcCtD
Buprenorphine—Insomnia—Citalopram—alcohol dependence	3.62e-05	0.000813	CcSEcCtD
Buprenorphine—ABCB1—blood—alcohol dependence	3.6e-05	0.00324	CbGeAlD
Buprenorphine—Paraesthesia—Citalopram—alcohol dependence	3.6e-05	0.000807	CcSEcCtD
Buprenorphine—Dyspnoea—Citalopram—alcohol dependence	3.57e-05	0.000801	CcSEcCtD
Buprenorphine—Somnolence—Citalopram—alcohol dependence	3.56e-05	0.000799	CcSEcCtD
Buprenorphine—ABCB1—midbrain—alcohol dependence	3.55e-05	0.0032	CbGeAlD
Buprenorphine—Dyspepsia—Citalopram—alcohol dependence	3.53e-05	0.000791	CcSEcCtD
Buprenorphine—Decreased appetite—Citalopram—alcohol dependence	3.48e-05	0.000781	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Citalopram—alcohol dependence	3.46e-05	0.000776	CcSEcCtD
Buprenorphine—Fatigue—Citalopram—alcohol dependence	3.45e-05	0.000775	CcSEcCtD
Buprenorphine—Pain—Citalopram—alcohol dependence	3.43e-05	0.000769	CcSEcCtD
Buprenorphine—Constipation—Citalopram—alcohol dependence	3.43e-05	0.000769	CcSEcCtD
Buprenorphine—Feeling abnormal—Citalopram—alcohol dependence	3.3e-05	0.000741	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Citalopram—alcohol dependence	3.28e-05	0.000735	CcSEcCtD
Buprenorphine—Urticaria—Citalopram—alcohol dependence	3.18e-05	0.000714	CcSEcCtD
Buprenorphine—Abdominal pain—Citalopram—alcohol dependence	3.17e-05	0.00071	CcSEcCtD
Buprenorphine—Body temperature increased—Citalopram—alcohol dependence	3.17e-05	0.00071	CcSEcCtD
Buprenorphine—ABCB1—endocrine gland—alcohol dependence	3.12e-05	0.00281	CbGeAlD
Buprenorphine—CYP2D6—brain—alcohol dependence	3.1e-05	0.00279	CbGeAlD
Buprenorphine—ABCB1—testis—alcohol dependence	2.98e-05	0.00268	CbGeAlD
Buprenorphine—Hypersensitivity—Citalopram—alcohol dependence	2.95e-05	0.000662	CcSEcCtD
Buprenorphine—ABCB1—nervous system—alcohol dependence	2.92e-05	0.00263	CbGeAlD
Buprenorphine—Asthenia—Citalopram—alcohol dependence	2.87e-05	0.000645	CcSEcCtD
Buprenorphine—Pruritus—Citalopram—alcohol dependence	2.83e-05	0.000636	CcSEcCtD
Buprenorphine—ABCB1—liver—alcohol dependence	2.81e-05	0.00253	CbGeAlD
Buprenorphine—ABCB1—central nervous system—alcohol dependence	2.81e-05	0.00253	CbGeAlD
Buprenorphine—ABCB1—cerebellum—alcohol dependence	2.75e-05	0.00247	CbGeAlD
Buprenorphine—Diarrhoea—Citalopram—alcohol dependence	2.74e-05	0.000615	CcSEcCtD
Buprenorphine—Dizziness—Citalopram—alcohol dependence	2.65e-05	0.000594	CcSEcCtD
Buprenorphine—Vomiting—Citalopram—alcohol dependence	2.55e-05	0.000571	CcSEcCtD
Buprenorphine—Rash—Citalopram—alcohol dependence	2.53e-05	0.000567	CcSEcCtD
Buprenorphine—Dermatitis—Citalopram—alcohol dependence	2.52e-05	0.000566	CcSEcCtD
Buprenorphine—Headache—Citalopram—alcohol dependence	2.51e-05	0.000563	CcSEcCtD
Buprenorphine—Nausea—Citalopram—alcohol dependence	2.38e-05	0.000534	CcSEcCtD
Buprenorphine—ABCB1—brain—alcohol dependence	2.23e-05	0.00201	CbGeAlD
Buprenorphine—CYP2C19—Biological oxidations—POMC—alcohol dependence	5.99e-06	0.00019	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MAOB—alcohol dependence	5.98e-06	0.00019	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—OPRM1—alcohol dependence	5.94e-06	0.000189	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ADH6—alcohol dependence	5.94e-06	0.000189	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—AVP—alcohol dependence	5.94e-06	0.000189	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—DRD2—alcohol dependence	5.94e-06	0.000189	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR7—alcohol dependence	5.94e-06	0.000189	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—AVP—alcohol dependence	5.91e-06	0.000188	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ADH6—alcohol dependence	5.89e-06	0.000187	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ADH4—alcohol dependence	5.89e-06	0.000187	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—POMC—alcohol dependence	5.88e-06	0.000187	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—WASF1—alcohol dependence	5.79e-06	0.000184	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—DRD4—alcohol dependence	5.79e-06	0.000184	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—OPRD1—alcohol dependence	5.72e-06	0.000182	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CHRM2—alcohol dependence	5.68e-06	0.00018	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—POMC—alcohol dependence	5.63e-06	0.000179	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—HTR2A—alcohol dependence	5.61e-06	0.000178	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ADH1B—alcohol dependence	5.57e-06	0.000177	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	5.53e-06	0.000176	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CNR1—alcohol dependence	5.53e-06	0.000176	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—POMC—alcohol dependence	5.51e-06	0.000175	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PDYN—alcohol dependence	5.49e-06	0.000174	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GOT2—alcohol dependence	5.47e-06	0.000174	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NPY—alcohol dependence	5.47e-06	0.000174	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—POMC—alcohol dependence	5.46e-06	0.000173	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—DRD2—alcohol dependence	5.39e-06	0.000171	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR7—alcohol dependence	5.39e-06	0.000171	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—AVP—alcohol dependence	5.37e-06	0.000171	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ADH1A—alcohol dependence	5.35e-06	0.00017	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR1B—alcohol dependence	5.28e-06	0.000168	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CRH—alcohol dependence	5.28e-06	0.000168	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ADH1A—alcohol dependence	5.22e-06	0.000166	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—OPRM1—alcohol dependence	5.21e-06	0.000166	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CYP2E1—alcohol dependence	5.14e-06	0.000163	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—WASF2—alcohol dependence	5.1e-06	0.000162	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CRHR1—alcohol dependence	5.1e-06	0.000162	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ADH4—alcohol dependence	5.1e-06	0.000162	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HTR2A—alcohol dependence	5.09e-06	0.000162	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ALDH2—alcohol dependence	5.09e-06	0.000162	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MAOB—alcohol dependence	5.08e-06	0.000161	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ADH6—alcohol dependence	5.03e-06	0.00016	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MAOB—alcohol dependence	5.03e-06	0.00016	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ADH7—alcohol dependence	5.01e-06	0.000159	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—AVP—alcohol dependence	5e-06	0.000159	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ADH1A—alcohol dependence	4.92e-06	0.000156	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR2A—alcohol dependence	4.92e-06	0.000156	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—WASF1—alcohol dependence	4.89e-06	0.000155	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.89e-06	0.000155	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ADH1A—alcohol dependence	4.88e-06	0.000155	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GGT2—alcohol dependence	4.8e-06	0.000152	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CHRM2—alcohol dependence	4.8e-06	0.000152	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NPY—alcohol dependence	4.8e-06	0.000152	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GGT1—alcohol dependence	4.72e-06	0.00015	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GOT1—alcohol dependence	4.72e-06	0.00015	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—POMC—alcohol dependence	4.66e-06	0.000148	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CRH—alcohol dependence	4.63e-06	0.000147	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR1B—alcohol dependence	4.63e-06	0.000147	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—DRD4—alcohol dependence	4.61e-06	0.000147	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MAOB—alcohol dependence	4.61e-06	0.000147	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ADH4—alcohol dependence	4.55e-06	0.000145	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—AVP—alcohol dependence	4.54e-06	0.000144	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—POMC—alcohol dependence	4.48e-06	0.000142	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HTR2A—alcohol dependence	4.47e-06	0.000142	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ADH4—alcohol dependence	4.44e-06	0.000141	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	4.41e-06	0.00014	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CNR1—alcohol dependence	4.4e-06	0.00014	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ADH1B—alcohol dependence	4.39e-06	0.000139	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ADH7—alcohol dependence	4.34e-06	0.000138	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GOT2—alcohol dependence	4.33e-06	0.000137	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ALDH2—alcohol dependence	4.32e-06	0.000137	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR7—alcohol dependence	4.3e-06	0.000136	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—DRD2—alcohol dependence	4.3e-06	0.000136	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ALDH2—alcohol dependence	4.28e-06	0.000136	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—MAOA—alcohol dependence	4.23e-06	0.000134	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ADH4—alcohol dependence	4.19e-06	0.000133	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ADH1A—alcohol dependence	4.17e-06	0.000132	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR2A—alcohol dependence	4.16e-06	0.000132	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GGT2—alcohol dependence	4.16e-06	0.000132	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ADH4—alcohol dependence	4.15e-06	0.000132	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—POMC—alcohol dependence	4.07e-06	0.000129	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CYP2E1—alcohol dependence	4.07e-06	0.000129	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NPY—alcohol dependence	4.05e-06	0.000129	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—DRD4—alcohol dependence	4.04e-06	0.000128	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.94e-06	0.000125	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—POMC—alcohol dependence	3.93e-06	0.000125	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALDH2—alcohol dependence	3.92e-06	0.000125	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CRH—alcohol dependence	3.91e-06	0.000124	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR1B—alcohol dependence	3.91e-06	0.000124	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ADH6—alcohol dependence	3.88e-06	0.000123	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	3.88e-06	0.000123	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ADH7—alcohol dependence	3.87e-06	0.000123	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CNR1—alcohol dependence	3.86e-06	0.000123	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ADH1B—alcohol dependence	3.8e-06	0.000121	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ADH7—alcohol dependence	3.78e-06	0.00012	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR2A—alcohol dependence	3.78e-06	0.00012	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR7—alcohol dependence	3.77e-06	0.00012	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—DRD2—alcohol dependence	3.77e-06	0.00012	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—EP300—alcohol dependence	3.74e-06	0.000119	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GOT1—alcohol dependence	3.73e-06	0.000119	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GGT1—alcohol dependence	3.73e-06	0.000119	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GGT2—alcohol dependence	3.71e-06	0.000118	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GOT2—alcohol dependence	3.67e-06	0.000117	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GOT2—alcohol dependence	3.64e-06	0.000116	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MAOB—alcohol dependence	3.64e-06	0.000116	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GGT2—alcohol dependence	3.62e-06	0.000115	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—AVP—alcohol dependence	3.62e-06	0.000115	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—POMC—alcohol dependence	3.6e-06	0.000114	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.59e-06	0.000114	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—POMC—alcohol dependence	3.57e-06	0.000113	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	3.56e-06	0.000113	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ADH7—alcohol dependence	3.56e-06	0.000113	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ADH4—alcohol dependence	3.55e-06	0.000113	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ADH7—alcohol dependence	3.53e-06	0.000112	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CYP2E1—alcohol dependence	3.45e-06	0.00011	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CYP2E1—alcohol dependence	3.42e-06	0.000109	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—DRD4—alcohol dependence	3.42e-06	0.000109	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GGT2—alcohol dependence	3.41e-06	0.000108	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ADH1B—alcohol dependence	3.39e-06	0.000108	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GGT2—alcohol dependence	3.38e-06	0.000107	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MAOA—alcohol dependence	3.35e-06	0.000106	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GOT2—alcohol dependence	3.33e-06	0.000106	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—POMC—alcohol dependence	3.32e-06	0.000105	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ADH1B—alcohol dependence	3.31e-06	0.000105	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CNR1—alcohol dependence	3.26e-06	0.000104	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.24e-06	0.000103	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ADH1A—alcohol dependence	3.22e-06	0.000102	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	3.21e-06	0.000102	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR7—alcohol dependence	3.18e-06	0.000101	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—DRD2—alcohol dependence	3.18e-06	0.000101	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—AVP—alcohol dependence	3.17e-06	0.000101	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GGT1—alcohol dependence	3.17e-06	0.000101	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GOT1—alcohol dependence	3.17e-06	0.000101	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MAOB—alcohol dependence	3.15e-06	0.0001	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GOT1—alcohol dependence	3.14e-06	9.98e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GGT1—alcohol dependence	3.14e-06	9.98e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CYP2E1—alcohol dependence	3.14e-06	9.96e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ADH1B—alcohol dependence	3.12e-06	9.91e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ADH1B—alcohol dependence	3.09e-06	9.83e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALDH2—alcohol dependence	3.09e-06	9.82e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.07e-06	9.75e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ADH7—alcohol dependence	3.02e-06	9.58e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—POMC—alcohol dependence	3.02e-06	9.58e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR2A—alcohol dependence	3.01e-06	9.56e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GGT2—alcohol dependence	2.89e-06	9.18e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GOT1—alcohol dependence	2.88e-06	9.14e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GGT1—alcohol dependence	2.88e-06	9.14e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MAOA—alcohol dependence	2.84e-06	9.02e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MAOA—alcohol dependence	2.81e-06	8.94e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MAOB—alcohol dependence	2.81e-06	8.93e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—POMC—alcohol dependence	2.76e-06	8.75e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MAOB—alcohol dependence	2.74e-06	8.72e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ADH4—alcohol dependence	2.74e-06	8.69e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—AVP—alcohol dependence	2.68e-06	8.51e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALDH2—alcohol dependence	2.68e-06	8.51e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ADH1B—alcohol dependence	2.64e-06	8.4e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR2A—alcohol dependence	2.64e-06	8.38e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GOT2—alcohol dependence	2.63e-06	8.35e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MAOB—alcohol dependence	2.59e-06	8.22e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MAOA—alcohol dependence	2.58e-06	8.19e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.58e-06	8.18e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MAOB—alcohol dependence	2.56e-06	8.14e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP2E1—alcohol dependence	2.47e-06	7.85e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—POMC—alcohol dependence	2.4e-06	7.63e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALDH2—alcohol dependence	2.39e-06	7.6e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALDH2—alcohol dependence	2.33e-06	7.41e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ADH7—alcohol dependence	2.33e-06	7.39e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.3e-06	7.3e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GOT2—alcohol dependence	2.28e-06	7.24e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GOT1—alcohol dependence	2.27e-06	7.21e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GGT1—alcohol dependence	2.27e-06	7.21e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GGT2—alcohol dependence	2.23e-06	7.09e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR2A—alcohol dependence	2.23e-06	7.08e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALDH2—alcohol dependence	2.2e-06	6.99e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MAOB—alcohol dependence	2.19e-06	6.96e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALDH2—alcohol dependence	2.18e-06	6.93e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—POMC—alcohol dependence	2.18e-06	6.92e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP2E1—alcohol dependence	2.14e-06	6.8e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—POMC—alcohol dependence	2.11e-06	6.69e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.1e-06	6.66e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.04e-06	6.48e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MAOA—alcohol dependence	2.03e-06	6.46e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GOT2—alcohol dependence	2.03e-06	6.46e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GOT2—alcohol dependence	1.98e-06	6.3e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GGT1—alcohol dependence	1.97e-06	6.25e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GOT1—alcohol dependence	1.97e-06	6.25e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP2E1—alcohol dependence	1.91e-06	6.07e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GOT2—alcohol dependence	1.87e-06	5.94e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP2E1—alcohol dependence	1.87e-06	5.93e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALDH2—alcohol dependence	1.86e-06	5.92e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GOT2—alcohol dependence	1.85e-06	5.89e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—POMC—alcohol dependence	1.85e-06	5.87e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—POMC—alcohol dependence	1.83e-06	5.82e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—EP300—alcohol dependence	1.83e-06	5.81e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.79e-06	5.69e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—POMC—alcohol dependence	1.78e-06	5.66e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MAOA—alcohol dependence	1.76e-06	5.6e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	1.76e-06	5.58e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GGT1—alcohol dependence	1.75e-06	5.57e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GOT1—alcohol dependence	1.75e-06	5.57e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP2E1—alcohol dependence	1.74e-06	5.54e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GGT1—alcohol dependence	1.71e-06	5.44e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GOT1—alcohol dependence	1.71e-06	5.44e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.71e-06	5.43e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MAOB—alcohol dependence	1.69e-06	5.37e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—POMC—alcohol dependence	1.68e-06	5.33e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GGT1—alcohol dependence	1.61e-06	5.13e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GOT1—alcohol dependence	1.61e-06	5.13e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GGT1—alcohol dependence	1.6e-06	5.08e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GOT1—alcohol dependence	1.6e-06	5.08e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—EP300—alcohol dependence	1.59e-06	5.06e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GOT2—alcohol dependence	1.58e-06	5.03e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MAOA—alcohol dependence	1.57e-06	5e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MAOA—alcohol dependence	1.53e-06	4.88e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.53e-06	4.84e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP2E1—alcohol dependence	1.49e-06	4.73e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MAOA—alcohol dependence	1.45e-06	4.59e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—EP300—alcohol dependence	1.45e-06	4.59e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.44e-06	4.57e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MAOA—alcohol dependence	1.43e-06	4.56e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EP300—alcohol dependence	1.4e-06	4.44e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.39e-06	4.42e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GOT1—alcohol dependence	1.37e-06	4.34e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GGT1—alcohol dependence	1.37e-06	4.34e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—POMC—alcohol dependence	1.32e-06	4.21e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—EP300—alcohol dependence	1.23e-06	3.89e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MAOA—alcohol dependence	1.23e-06	3.89e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GOT2—alcohol dependence	1.22e-06	3.88e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—EP300—alcohol dependence	1.22e-06	3.86e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.19e-06	3.77e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EP300—alcohol dependence	1.18e-06	3.75e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.15e-06	3.65e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—POMC—alcohol dependence	1.15e-06	3.64e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—EP300—alcohol dependence	1.11e-06	3.54e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GOT1—alcohol dependence	1.06e-06	3.35e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GGT1—alcohol dependence	1.06e-06	3.35e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—POMC—alcohol dependence	1.02e-06	3.25e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—POMC—alcohol dependence	9.99e-07	3.17e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MAOA—alcohol dependence	9.46e-07	3e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—POMC—alcohol dependence	9.42e-07	2.99e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—POMC—alcohol dependence	9.34e-07	2.97e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—EP300—alcohol dependence	8.79e-07	2.79e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—POMC—alcohol dependence	7.98e-07	2.53e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—EP300—alcohol dependence	7.61e-07	2.42e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—EP300—alcohol dependence	6.79e-07	2.16e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—EP300—alcohol dependence	6.63e-07	2.11e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—EP300—alcohol dependence	6.25e-07	1.98e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—EP300—alcohol dependence	6.19e-07	1.97e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—POMC—alcohol dependence	6.16e-07	1.96e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—EP300—alcohol dependence	5.29e-07	1.68e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—EP300—alcohol dependence	4.08e-07	1.3e-05	CbGpPWpGaD
